Skip to main content

Table 1 Baseline characteristics of study cohort

From: Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States

  All HAE patients (N = 631)
Sex, n (%)
 Female 448 (71.0)
 Male 183 (29.0)
Age (years), mean (SD) 38.3 (15.3)
Age Distribution, n (%)
  <12 years (%) 17 (2.7)
 12 to <17 years (%) 27 (4.3)
 17 to <65 years (%) 565 (89.5)
  ≥65 years (%) 22 (3.5)
Geographic region of the US, n (%)
 East 171 (27.1)
 Midwest 167 (26.5)
 South 249 (39.5)
 West 44 (7.0)
Payer Type, n (%)
 Commercial 452 (71.6)
 Self-insured 160 (25.4)
 Medicaid 13 (2.1)
 Medicare Risk 2 (0.3)
 Othera 3 (0.5)
 Missing/unknown 1 (0.2)
Charlson Comorbidity Index, mean (SD) 0.35 (0.78)
  1. HAE hereditary angioedema, SD standard deviation
  2. aOther included 1 patient (0.2%) each with the following: Medicare Cost (supplemental), State Children’s Health Insurance Program, Rx Only